Abstract 4260: PT886, an anti-claudin18.2/anti-CD47 bispecific antibody constructed with the PACbody and SPECpair technology platforms, exhibits robust anti-tumor activity in a pancreatic cancer xenograft modelJack Li, Hui Zou, Kelan Chen et al.|Cancer Research|2022Cited by 7
Abstract 4259: PT199, a next generation anti-CD73 mAb that inhibits both membrane-bound and soluble CD73 activity to completion without “hook effect”Haiqun Jia, Hui Zou, Jack Li et al.|Cancer Research|2022Cited by 4